← Open Payments lookup

ROBERT KIRK: Open Payments

NPI 1740686369 · AUDUBON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$632 in 25 payments from 11 companies in 2025. Trend: 2023 $166 · 2024 $82 · 2025 $632

Food & beverage: $632
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$160
Merz Pharmaceuticals, LLC1$117
EMD Serono, Inc.6$97
ANI Pharmaceuticals, Inc.4$75
ABBVIE INC.4$65
ACADIA Pharmaceuticals Inc2$31
Neurocrine BioSciences, Inc.1$20
Amneal Pharmaceuticals LLC1$18
SCILEX PHARMACEUTICALS INC.1$18
Otsuka America Pharmaceutical, Inc.1$16

Products named: CAPLYTA, INBRIJA, PURIFIED CORTROPHIN GEL, VRAYLAR, NUPLAZID, INGREZZA, CREXONT, ELYXYB - CELECOXIB.

Industry payments across NJ — which companies pay providers there.